Medical Properties Trust, Inc.

As of June 30, 2026, Medical Properties Trust, Inc. carries a market capitalization of 2.43B, placing it among publicly traded companies globally. Its enterprise value stands at 10.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medical Properties Trust, Inc.'s next confirmed earnings release is scheduled for October 22, 2026.

As of June 30, 2026, Medical Properties Trust, Inc. has 596.79M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.74, and the price-to-book ratio stands at 0.62.

As of June 30, 2026, Medical Properties Trust, Inc. trades at an EV/EBITDA multiple of 17.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.96 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 28.69 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 10.67B versus a market cap of 2.43B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Medical Properties Trust, Inc. maintains a current ratio of 1.40, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 217.80, indicating elevated leverage, while an interest coverage ratio of 1.77 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. posted a negative return on equity (ROE) of -0.65, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.20, reflecting losses generated across the asset base. The company generates approximately 7.42M in revenue per employee across its workforce of 120.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. recorded an income tax benefit of -2.95M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -28.36M and -26.42M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on September 9, 2026, Medical Properties Trust, Inc.'s stock has declined approximately 14.56% over the past 52 weeks. The 50-day moving average sits at 3.80, while the 200-day moving average is 4.24.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. generated 892.12M in revenue and converted that into -26.42M in net income, yielding earnings per share of -0.04. EBITDA reached 622.22M, while operating income came in at 505.02M.

As of June 30, 2026, Medical Properties Trust, Inc. holds 347.11M in cash and equivalents against 8.58B in total debt, resulting in a net debt position of 8.15B. Total book value stands at 3.94B, with working capital of 405.48M providing operational flexibility.

Medical Properties Trust, Inc. produced 198.54M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. posted a gross margin of 96.11, reflecting its pricing power and cost economics. The operating margin of 56.61 and net profit margin of -2.96 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Medical Properties Trust, Inc. paid dividends of 0.30 per share. The dividend payout ratio of -739.94 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 8.12, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.70, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Medical Properties Trust, Inc. shareholders.